2759. Cefiderocol vs Best Available Therapy for the Treatment of Carbapenem- Resistant Acinetobacter baumannii

BACKGROUND: Cefiderocol has been evaluated as a treatment of carbapenem-resistant gram negative infections. However robust data for the optimal approach to treat carbapenem-resistant Acinetobacter baumannii (CRAB) is lacking. The purpose of this study was to evaluate the efficacy of cefiderocol vs b...

Descripción completa

Detalles Bibliográficos
Autores principales: Daisey, Gabrielle N, Vyas, Nikunj M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678626/
http://dx.doi.org/10.1093/ofid/ofad500.2370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678626/
http://dx.doi.org/10.1093/ofid/ofad500.2370

Ejemplares similares